
 - original (ppt or pptx) presentations with recorded narration
- (ppt or pptx) slides only
- (pdf) handouts (two slides per page)
|
REACH, risk assessment and the need for a change in mind set | Kees van Leeuwen | |  |  |
A Framework for Building Toxicity Pathways to Complex Endpoints | Gilman Veith |  |  |  |
Status of the Glutathione Reactivity Database for Skin Sensitisation | Terry Schultz |  |  |  |
Estimating Human Health Endpoints with the QSAR Application Toolbox | Ovanes Mekenyan |  |  |  |
Progress Report from the IQF Consortium for Skin Sensitization Models | Mike Comber |  |  |  |
A Visualization Tool for Integrating Complex Toxicity Pathways | Hristo Aladjov |  |  |  |
Predicting In Vivo Toxicity from In Vitro Data | James McKim IV | |  |  |
Overview of Mitochondrial Bioenergetics & Molecular Biology | Kendall Wallace | |  |  |
Clinical Phenotype of Mitochondrial Disease | Charles Hoppel | |  |  |
QSAR Features for Inhibitors of Mitochondrial Bioenergetics | Anatoly Starkov | |  |  |
Mechanisms of Mitochondrial-Mediated Cell Injury | Peter O’Brien |  |  |  |
Metabolomic & Molecular Markers of Mitochondrial Toxicity | Kendall Wallace | |  |  |
A Review of QSAR Models for Mitochondrial Effects in BioLoom | Albert Leo |  |  |  |
Discussion of Chemical Targets in Mitochondria | Gilman Veith |  |  |  |
Delineating Toxicity Pathways for ER Mediated Effects | Patricia Schmieder | |  |  |
Focusing on the Adverse Outcomes of ER-mediated Pathways | Rodney Johnson | |  |  |
Delineating Thyroid-Mediated Toxicity Pathways | Michael Hornung | |  |  |
Thyroid-mediated CNS Dysfunction | Kevin Crofton |  |  |  |
Thyroid Discussion | Discussion |  |  |  |
Delineating Toxicity Pathways of Peripheral Neuropathy | David Herr |  |  |  |
Inhibition and Morphogenic Pathways Involving AChE | Steve Brimijoin |  |  |  |
Toxicity Pathways Mediated by Ion Channels | Philip Bushnell |  |  |  |
Stress Pathways | Steve Simmons | |  |  |